AI Tool Reduces Stroke Risk by 25 Percent in Large Trial

A major clinical trial in China known as GOLDEN BRIDGE II has revealed that an artificial intelligence tool significantly improves stroke care ^[1]. The study, published in The BMJ, found that AI-based decision support reduced recurrent vascular events by more than 25% ^[1][2]. Researchers also noted a marked increase in patient adherence to evidence-based treatment protocols ^[1]. The tool provides clinicians with data-driven guidance to manage stroke recovery more effectively ^[2]. By integrating AI into the workflow, hospitals can ensure patients receive standardized care tailored to their specific needs ^[1]. This development marks a significant step forward for digital health interventions in large-scale clinical settings ^[2].